Akram Mushtaha, M.D., M.S
Pediatric Allergy/Immunology Physician in Pasadena, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 422 in Pediatric Allergy/Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Akram Mushtaha, M.D., M.S filed 590 Medicare Part D claims in 2023 as a Pediatric Allergy/Immunology Physician in Pasadena, Texas, prescribing 78% generic.
- 590
- Part D claims, 2023
- 78%
- generic prescribing
- $175.07
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Akram Mushtaha, M.D., M.S's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
590 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Akram Mushtaha, M.D., M.S practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Akram Mushtaha, M.D., M.S?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Pediatric Allergy/Immunology Physician compares to other specialties among Texas providers
Pediatric Allergy/Immunology Physician ranks #354 among Texas's specialties (0% of in-state providers)
Each bar is a specialty's share of the Texas provider total, by primary NUCC taxonomy. The highlighted bar is Pediatric Allergy/Immunology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pediatric Allergy/Immunology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Akram Mushtaha, M.D., M.S appears in the CMS NPPES registry as a Pediatric Allergy/Immunology Physician provider holding M.D., M.S credentials at 5048 CRENSHAW RD # 100, Pasadena, TX, 77505, with a listed phone of (713) 475-5863. NPI 1598942203 was issued on 01/24/2008.
Medicare Part D records for calendar year 2023 show 590 prescription claims written by this provider, covering 92 Medicare beneficiaries and totaling roughly $200K in drug spend, split 22% brand-name and 78% generic by claim count.
Pediatric Allergy/Immunology Physician is a narrow specialty nationwide, with 422 enrolled providers across 43 states and an average of 345 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1598942203 |
|---|---|
| Specialty | Pediatric Allergy/Immunology Physician |
| Credentials | M.D., M.S |
| Gender | Male |
| NPI Issued | 01/24/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Akram Mushtaha, M.D., M.S's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1598942203 is the unique 10-digit identifier CMS uses to link Mushtaha across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Akram Mushtaha, M.D., M.S. Source: openpaymentsdata.cms.gov.
Total received
$175
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Akram Mushtaha, M.D., M.S. To verify Akram Mushtaha, M.D., M.S's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
22% brand-name claims vs 78% generic, on 590 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 859
- Total Day Supply
- 23,720
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $189K
- Generic Drug Cost
- $11K
- Antibiotic Claims
- 18
Patient Demographics
- Average Patient Age
- 69.6 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 78% female / 22% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Akram Mushtaha, M.D., M.S prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
145 claims
- Fluticasone Propio…
Fluticasone Propionate
104 claims
- Albuterol Sulfate … 55
Albuterol Sulfate Hfa
55 claims
- Azelastine Hcl 48
Azelastine Hcl
48 claims
- Mometasone Furoate 35
Mometasone Furoate
35 claims
- Breo Ellipta 32
Breo Ellipta
32 claims
- Prednisone 24
Prednisone
24 claims
- Famotidine 22
Famotidine
22 claims
| Drug | Claims |
|---|---|
| Levocetirizine Dihydrochloride | 145 |
| Fluticasone Propionate | 104 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 55 |
| Azelastine Hcl | 48 |
| Mometasone Furoate | 35 |
| Breo Ellipta Fluticasone/Vilanterol | 32 |
| Prednisone | 24 |
| Famotidine | 22 |
| Montelukast Sodium | 22 |
| Fasenra Benralizumab | 21 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Allergy/Immunology Physician Overview
How Akram Mushtaha, M.D., M.S fits within the Pediatric Allergy/Immunology Physician landscape nationally.
Akram Mushtaha, M.D., M.S's 590 claims are above the specialty average of 345.
Nearby Pediatric Allergy/Immunology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Mushtaha.
Compare Pediatric Allergy/Immunology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Allergy/Immunology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is Akram Mushtaha, M.D., M.S's specialty? ▼
How much does Akram Mushtaha, M.D., M.S prescribe under Medicare Part D? ▼
Where is Akram Mushtaha, M.D., M.S located? ▼
What is Akram Mushtaha, M.D., M.S's NPI number? ▼
Does Akram Mushtaha, M.D., M.S prescribe more brand-name or generic drugs? ▼
How many Pediatric Allergy/Immunology Physician providers are there in the US? ▼
What drugs does Akram Mushtaha, M.D., M.S prescribe most often? ▼
Does Akram Mushtaha, M.D., M.S accept Medicare? ▼
How can I verify Akram Mushtaha, M.D., M.S's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.